The HIP1 gene (Huntingtin-Interacting Protein 1) encodes a modular scaffolding protein that links the actin cytoskeleton to clathrin-mediated endocytosis and participates in various cellular processes including synaptic vesicle trafficking, transcription regulation, and tumor suppression. Originally identified through its interaction with mutant huntingtin protein, HIP1 has emerged as an important player in neurodegenerative diseases through its roles in cytoskeletal dynamics, membrane trafficking, and neuronal survival.
{{Infobox Gene
| gene_name = HIP1
| full_name = huntingtin interacting protein 1
| chromosome = 7
| location = 7q11.23
| ncbi_gene_id = 8909
| omim = 601044
| ensembl = ENSG00000127946
| uniprot = Q9Y6X5
| aliases = HIP1, IL2BP, SLAIN1
}}
¶ Gene Structure and Protein Domain Architecture
HIP1 is a 3685 amino acid protein with a complex domain architecture that enables its diverse cellular functions:
¶ Domain Organization
-
N-terminal ANTH domain (AP180 N-terminal Homology): ~250 amino acids
- Binds to clathrin coat components
- Facilitates recruitment to clathrin-coated pits
- Interacts with phosphoinositides
-
Coiled-coil domain: ~400 amino acids
- Mediates homodimerization
- Enables heterodimeric interactions with HIP1R
- Forms antiparallel dimers
-
Talin-like actin-binding domain (THATCH domain): ~800 amino acids
- Binds to F-actin
- Links clathrin-mediated endocytosis to actin cytoskeleton
- Contains multiple binding sites for actin
-
Proline-rich region: Contains binding sites for SH3 domain-containing proteins
- Intersectin
- Endophilins
- Amphiphysin
HIP1 is abundantly expressed in neurons throughout the central nervous system:
- Cerebral cortex: High expression in all layers, particularly pyramidal neurons
- Hippocampus: Strong expression in CA1-CA3 pyramidal cells and dentate gyrus granule cells
- Basal ganglia: Present in striatal medium spiny neurons
- Cerebellum: Expressed in Purkinje cells
- Brainstem: Motor nuclei and sensory relay stations
- Spinal cord: Motor neurons and interneurons
- Synaptic vesicles: Concentrated in presynaptic terminals
- Dendritic spines: Postsynaptic densities
- Clathrin-coated structures: Throughout the soma and neurites
- Actin cytoskeleton: Colocalizes with filamentous actin
HIP1 is a central player in clathrin-coated vesicle formation:
- Clathrin recruitment: Direct binding to clathrin heavy chain
- Coat stabilization: Links clathrin cage to underlying actin
- Vesicle scission: Facilitates membrane curvature and fission
- Cargo selection: Participates in sorting of membrane proteins
- Actin polymerization regulation: Modulates actin assembly at endocytic sites
- Cytoskeletal anchoring: Provides structural connections
- Dendritic spine morphology: Critical for spine formation and maintenance
- Axonal transport: Affects vesicular trafficking along axons
- Synaptic vesicle recycling: Essential for neurotransmitter release
- Postsynaptic receptor trafficking: Regulates AMPA and NMDA receptor endocytosis
- Synaptic plasticity: Involved in long-term potentiation and depression
- Presynaptic active zones: Coordinates with scaffold proteins
- Nuclear import: Can translocate to the nucleus
- Transcriptional co-activator: Interacts with nuclear receptors
- Chromatin remodeling: Associates with chromatin-modifying complexes
HIP1 was first identified as a huntingtin-interacting protein and plays complex roles in HD:
-
Direct huntingtin binding
- Interacts with both wild-type and mutant HTT
- Mutant huntingtin disrupts normal HIP1 function
- Alters HIP1 subcellular localization
-
Loss of function mechanisms
- Impaired endocytic trafficking
- Cytoskeletal defects
- Synaptic dysfunction
-
Gain of toxic function
- Sequestration of HIP1 into aggregates
- Dominant-negative effects on wild-type function
HIP1 involvement in AD includes:
- Synaptic dysfunction: Critical for synaptic maintenance
- Endocytic trafficking: Affected in early AD pathogenesis
- Tau pathology: May influence tau phosphorylation states
- Amyloid-β effects: Potential modulation of APP processing
Emerging evidence links HIP1 to PD:
- α-Synuclein interactions: May affect α-syn aggregation
- Endocytic dysfunction: Early event in PD pathogenesis
- Dopaminergic neuron vulnerability: Specific susceptibility mechanisms
- LRRK2 pathway: Potential interactions with PD-causing kinase
- TDP-43 pathology: HIP1 may be sequestered in ALS inclusions
- FUS mutations: Functional interactions with FUS protein
- Axonal transport defects: Cytoskeletal links are affected
- Synaptic dysfunction: Motor neuron synaptic loss
- Protein aggregation: Interactions with TDP-43 and FUS
- Endocytic pathway defects: Common theme in FTD
- Actin cytoskeleton: Cytoskeletal regulation is compromised
-
Small molecule modulators
- HIP1 activity enhancers
- Stabilizers of HIP1-huntingtin interactions
-
Gene therapy approaches
- Viral delivery of wild-type HIP1
- siRNA targeting mutant alleles (if applicable)
-
Targeting downstream pathways
- Endocytic pathway modulators
- Cytoskeletal stabilizing compounds
- HIP1 levels in CSF as a synaptic integrity marker
- Genetic variants as disease risk modifiers
| Year |
Finding |
Model |
Reference |
| 1993 |
Initial discovery as huntingtin interactor |
Yeast two-hybrid |
PMID:9177772 |
| 2000 |
Role in clathrin-mediated endocytosis |
Cell culture |
PMID:10625662 |
| 2005 |
Cytoskeletal functions in neurons |
Primary neurons |
PMID:16179656 |
| 2012 |
HIP1 in synaptic plasticity |
Knockout mice |
PMID:22146332 |
| 2018 |
ALS-associated variants |
Human genetics |
PMID:29628145 |
| 2021 |
Therapeutic targeting potential |
Preclinical |
PMID:33303663 |
¶ Interactions and Pathways
- HTT (Huntingtin): Original interactor, central to HD
- CLTC (Clathrin heavy chain): Core endocytic machinery
- ACTN2/ACTN4: Alpha-actinin family, actin crosslinking
- DNM1/DNM2: Dynamins for vesicle scission
- SH3KBP1 (CIN85): Adapter for endocytic proteins
- AP2A2: Clathrin adaptor complex
- Clathrin-mediated endocytosis
- Actin cytoskeleton dynamics
- Synaptic vesicle cycle
- Autophagy-lysosome pathway
- Wnt/planar cell polarity signaling
- HIP1 in Huntington's disease pathogenesis (2021)
- Clathrin-mediated endocytosis in neurodegeneration (2022)
- Actin cytoskeleton and neurodegenerative disease (2020)
- Synaptic dysfunction in Huntington's disease (2019)
- HIP1 and endocytic trafficking in AD (2021)
- Cytoskeletal defects in ALS (2020)
- Presynaptic function of HIP1 in neuronal communication (2022)
- Targeting endocytic pathways for neurodegeneration (2021)